1. Home
  2. CERS vs KBSX Comparison

CERS vs KBSX Comparison

Compare CERS & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • KBSX
  • Stock Information
  • Founded
  • CERS 1991
  • KBSX 1976
  • Country
  • CERS United States
  • KBSX Taiwan
  • Employees
  • CERS N/A
  • KBSX N/A
  • Industry
  • CERS EDP Services
  • KBSX Recreational Games/Products/Toys
  • Sector
  • CERS Technology
  • KBSX Consumer Discretionary
  • Exchange
  • CERS Nasdaq
  • KBSX Nasdaq
  • Market Cap
  • CERS 347.3M
  • KBSX 299.4M
  • IPO Year
  • CERS 1997
  • KBSX N/A
  • Fundamental
  • Price
  • CERS $1.29
  • KBSX $1.96
  • Analyst Decision
  • CERS Strong Buy
  • KBSX
  • Analyst Count
  • CERS 2
  • KBSX 0
  • Target Price
  • CERS $3.50
  • KBSX N/A
  • AVG Volume (30 Days)
  • CERS 1.0M
  • KBSX 273.5K
  • Earning Date
  • CERS 05-01-2025
  • KBSX 04-25-2025
  • Dividend Yield
  • CERS N/A
  • KBSX N/A
  • EPS Growth
  • CERS N/A
  • KBSX N/A
  • EPS
  • CERS N/A
  • KBSX N/A
  • Revenue
  • CERS $185,144,000.00
  • KBSX $33,935,076.00
  • Revenue This Year
  • CERS $25.57
  • KBSX N/A
  • Revenue Next Year
  • CERS $10.54
  • KBSX N/A
  • P/E Ratio
  • CERS N/A
  • KBSX N/A
  • Revenue Growth
  • CERS 13.06
  • KBSX N/A
  • 52 Week Low
  • CERS $1.12
  • KBSX $1.26
  • 52 Week High
  • CERS $2.54
  • KBSX $15.48
  • Technical
  • Relative Strength Index (RSI)
  • CERS 45.00
  • KBSX N/A
  • Support Level
  • CERS $1.22
  • KBSX N/A
  • Resistance Level
  • CERS $1.38
  • KBSX N/A
  • Average True Range (ATR)
  • CERS 0.07
  • KBSX 0.00
  • MACD
  • CERS 0.00
  • KBSX 0.00
  • Stochastic Oscillator
  • CERS 26.92
  • KBSX 0.00

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high-performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: